Luis M. Montuenga

机构：Clinica Universidad de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Universidad de Navarra · ORCID：0000-0002-8739-1387

发表论文 529 篇 · 总被引 14721 次 · h-index 61

代表论文

• Tumor cell-expressed OX40L enhances the efficacy of PD-1 axis blockade in non-small cell lung cancer (2026 · Journal for ImmunoTherapy of Cancer)
• Ordinal deep learning for pulmonary nodule risk assessment: an external validation study on a novel screening cohort (2026 · Zenodo (CERN European Organization for Nuclear Research))
• Ordinal deep learning for pulmonary nodule risk assessment: an external validation study on a novel screening cohort (2026 · Zenodo (CERN European Organization for Nuclear Research))
• Targeting the DSTYK-ULK1 axis rewires TNFR1 signaling to overcome treatment resistance in lung cancer (2026 · Cell Reports)
• Supplementary Figure 2 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells (2025)
• Supplementary Figure 3 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells (2025)